Fig. 1 · Structure

Documents & Downloads

Diprophylline

Cat. No. A11971 CAS 72376-77-3

AR antagonist

Diprophylline is a xanthine derivative with bronchodilator and vasodilator effects.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Diprophylline Research Summary

This section summarizes 2 in vitro studies and 2 in vivo studies of Diprophylline from 3 published references. In vitro models include A549 cells. In vivo models include 1-2 cell zebrafish embryos.

Diprophylline In Vitro Studies

In A549 cells, Diprophylline at 1 or 10 µM decreased proliferation in a time-dependent manner compared with the DMSO control, with significantly decreased optical density values at 48 and 72 h. In rat jejunal segments in a normal contractile state, Diprophylline increased contractile amplitude at 5~40 µM and decreased it at 80~160 µM. [1,2]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Cell proliferation in lung cell cultures

Cell-based study · A549 cells [1]

A549 cells incubated with Diprophylline at 1 or 10 µM showed a time-dependent decrease in proliferation compared with the DMSO control. Optical density values were significantly decreased at 48 and 72 h.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
the optical density (OD) was measured at 450 nmReported result Following administration of 1 or 10 µM DPL, the proliferation of A549 cells treated with DPL decreased in a time-dependent manner, compared with the control group, and the OD values were significantly decreased at 48 and 72 h, compared with the control (P<0.05).[1]

Literature-Reported Treatment Conditions

Treatment concentration
1 or 10 µM
Exposure duration
0, 24, 48 and 72 h
Method
Cells were incubated with
Vehicle
1% DMSO culture medium
Methods and source locations

Compound reported in the paper: Diprophylline

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Materials and methods > Untitled > Cell proliferation assay (S10, S11, S12); Results > Untitled > DPL inhibits the proliferation of NSCLC A549 cells (S34, S39); Figure 1. legend (S59, S61)

the optical density (OD) was measured at 450 nm: the optical density (OD) was measured at 450 nm; comparator: 1% DMSO culture medium as the normal control group (NC) — Materials and methods > Untitled > Cell proliferation assay (S12); Results > Untitled > DPL inhibits the proliferation of NSCLC A549 cells (S39); Figure 1. legend (S59)

contractile amplitude of jejunal segment in Rat jejunal segments; normal contractile state

Cell-based study · Rat jejunal segments; normal contractile state [2]

Model: Rat jejunal segments; normal contractile state. Treatment: 5~40 µM; 80~160 µM. Result: In normal contractile state, Diprophylline increased the contractile amplitude of jejunal segment in a concentration range of 5~40 µM with an ED50 of 10 µM and decreased the contractile amplitude of jejunal segment in a concentration range of 80~160 µM with an ED50 of 80 µM..

Measured endpoints — not treatment concentrations
EndpointReported resultReference
contractile amplitude of jejunal segmentED50 Normal contractile state: 5~40 µM, ED50 of 10 µM; 80~160 µM, ED50 of 80 µM[2]

Literature-Reported Treatment Conditions

Treatment concentration
5~40 µM; 80~160 µM
Method
diprophylline was added
Reported limits
Not stated in the sentences used: schedule, vehicle.
Methods and source locations

Compound reported in the paper: Diprophylline

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

METHODS > Tissue preparation and contractility determination (S21); METHODS > Jejunal contractility measured in different contractile states (S27); RESULTS > Concentration-effects relationship of diprophylline (S48, S49); RESULTS > Relationship between jejunal contractile state and diprophylline-induced effects (S50)

contractile amplitude of jejunal segment: contractile amplitude of jejunal segment; comparator: amplitude before and after drug treatment — RESULTS > Concentration-effects relationship of diprophylline (S48, S49)

Diprophylline In Vivo Studies

In Sprague-Dawley CP rats, Diprophylline administered by gavage at 20 mg/kg once daily for 7 days significantly increased p-MLC20 compared with untreated CP rats. In zebrafish embryos injected into the yolk at the 1-2 cell stage, more than 90% survived at 72 hpf following Diprophylline treatment at 20 ng/embryo. [2,3]

Myosin light chain phosphorylation in CP rats

Animal study · Sprague-Dawley rats; CP rats [2]

In Sprague-Dawley CP rats, Diprophylline administered by gavage at 20 mg/kg once daily for 7 days significantly increased p-MLC20 compared with untreated CP rats.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
the phosphorylation of 20-kDa regulatory light chain of myosin (p-MLC20)Reported result Gavage of diprophylline (20 mg/kg) once daily for 7 days, P-MLC20 was significantly increased in diprophylline-treated CP rats compared with that of untreated CP rats.[2]

Conditions shared by the study groups

Route
Gavage
Treatment course
once daily for 7 days
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Diprophylline 20 mg/kguntreated CP ratsGavage of diprophylline (20 mg/kg) once daily for 7 days, P-MLC20 was significantly increased in diprophylline-treated CP rats compared with that of untreated CP rats.[2]
Diprophylline 20 mg/kg
Model: Sprague-Dawley rats; CP rats
Reported limits: Not stated in the sentences used: vehicle.
Methods and source locations

Compound reported in the paper: Diprophylline

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

METHODS > Experimental models of diarrhea and constipation (S12, S14); RESULTS > Underlying mechanisms involved in diprophylline-induced bidirectional modulation > 5. Diprophylline-induced bidirectional modulation on myosin-phosphorylation (S67); Fig. 5 legend (S92)

the phosphorylation of 20-kDa regulatory light chain of myosin (p-MLC20): the phosphorylation of 20-kDa regulatory light chain of myosin (p-MLC20); comparator: untreated CP rats — RESULTS > Underlying mechanisms involved in diprophylline-induced bidirectional modulation > 5. Diprophylline-induced bidirectional modulation on myosin-phosphorylation (S67); Fig. 5 legend (S92)

Diprophylline 20 mg/kg · RESULTS > Underlying mechanisms involved in diprophylline-induced bidirectional modulation > 5. Diprophylline-induced bidirectional modulation on myosin-phosphorylation (S67)

Survival of treated zebrafish embryos

Animal study · 1-2 cell zebrafish embryos [3]

Zebrafish embryos received Diprophylline at 20 ng/embryo by injection into the yolk. More than 90% of embryos survived at 72 hpf.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
survival percentage at 72 hpfsurvival more than 90% of embryos surviving[3]

Conditions shared by the study groups

Route
injected into the yolk
Treatment course
at 1-2 cell stage; at 72 hpf
Vehicle
sterile water
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Diprophylline 20 ng/embryoembryos injected with 0.05% phenol red in sterile watermore than 90% of embryos surviving at dose as high as 20 ng/embryo[3]
Diprophylline 20 ng/embryo
Model: 1-2 cell zebrafish embryos
Methods and source locations

Compound reported in the paper: Diprophylline

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Methods > Microinjection (S11, S14); Results > Embryotoxicity (S47, S53); Fig. 1 legend (S97, S98); Table 1 (T1.r3)

survival percentage at 72 hpf: survival percentage at 72 hpf; comparator: embryos injected with 0.05% phenol red in sterile water — Results > Embryotoxicity (S53); Fig. 1 legend (S98)

Diprophylline 20 ng/embryo · Results > Embryotoxicity (S47, S53); Fig. 1 legend (S97)

Specifications

Manufacturer Adooq Bioscience
Actions Antagonist
CAS Number 72376-77-3
Applications AR antagonist
Formula C10H14N4O4
Molecular Weight 254.24
Synonyms Dyphylline
SMILES
O=C2N(c1ncn(c1C(=O)N2C)CC(O)CO)C

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Diprophylline Research References

  1. [1] Zhao HY, Ren YH, Ren XB, et al. Diprophylline inhibits non-small cell lung cancer A549 cell proliferation and migration, and promotes apoptosis, by downregulating PI3K signaling pathway. Oncol Lett (2019). PMID: 30655839 DOI: 10.3892/ol.2018.9678 Source material
  2. [2] Liu FF, Chen DP, Xiong YJ, et al. Characteristics of diprophylline-induced bidirectional modulation on rat jejunal contractility. Korean J Physiol Pharmacol (2014). PMID: 24634596 DOI: 10.4196/kjpp.2014.18.1.47 Source material
  3. [3] Basnet RM, Zizioli D, Guarienti M, et al. Methylxanthines induce structural and functional alterations of the cardiac system in zebrafish embryos. BMC Pharmacol Toxicol (2017). PMID: 29141695 DOI: 10.1186/s40360-017-0179-9 Source material

Added to your cart

View Cart Checkout
Loading...